Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Pharvaris N.V. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 36 | 35 | −1 |
| Shares | 40.7M | 42.4M | +1.68M (+4.1%) |
| Value | $1.14B | $980.5M | −$162.5M (−14.2%) |
New holders (6)
Institutions that held Pharvaris N.V. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rock Springs Capital Management LP | 752,924 | $17.4M | 0.44% |
| TD Asset Management Inc | 112,616 | $2.60M | 0.00% |
| HighVista Strategies LLC | 16,750 | $387.1K | 0.14% |
| Jump Financial, LLC | 11,700 | $270.4K | 0.01% |
| Bank of America Corp | 7,808 | $180.4K | 0.00% |
| ADAR1 Capital Management, LLC | 2,000 | $46.2K | 0.01% |
Sold out (7)
Institutions that held Pharvaris N.V. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Vivo Capital, LLC | 285,000 | $7.99M |
| Blackstone Group Inc. | 100,000 | $2.81M |
| UBS Oconnor LLC | 18,000 | $504.9K |
| Schonfeld Strategic Advisors LLC | 12,400 | $347.8K |
| Two Sigma Investments, LP | 8,198 | $230.0K |
| Quarry LP | 750 | $21.0K |
| Piper Sandler & Co. | 181 | $5.08K |